The midlife transition and the risk of cardiovascular disease and cancer Part II: strategies to maximize quality of life and limit dysfunction and disease

Keyphrases

• Quality of Life 100%
• Cardiovascular Risk 100%
• Menopausal Hormone Therapy 100%
• Midlife Transition 100%
• Aging 50%
• Cardiovascular Disease 50%
• Clinical Application 50%
• Disability 50%
• Complex Disease 50%
• Repurposing 50%
• Clinical Research 50%
• Shared Decision Making 50%
• Therapeutic Program 50%
• Estradiol 50%
• Systemic Inflammatory Response 50%
• Pathogenic Mechanism 50%
• Minimum Risk 50%
• Metabolic 50%
• Clinical Problems 50%
• Laboratory Research 50%
• Treatment Burden 50%
• Diagnostic Management 50%
• Health Strategy 50%
• Osteoporosis 50%
• Menopause 50%
• Triage 50%
• Risk-benefit 50%
• Office Visits 50%
• Management Guidelines 50%
• Diagnostic Guidelines 50%
• Effective Care 50%
• Diabetes Mellitus Type 2 50%
• Visceral Obesity 50%
• Therapeutic Guidelines 50%
• Midlife Women 50%
• Maximum Benefit 50%

Medicine and Dentistry

• Quality of Life 100%
• Disease 100%
• Cardiovascular Disease 100%
• Hormone Therapy 100%
• Cardiovascular System Cancer 100%
• Malignant Neoplasm 50%
• Diagnosis 50%
• Maturity Onset Diabetes of the Young 50%
• Diethylstilbestrol 50%
• Triage 50%
• Shared Decision Making 50%
• Osteoporosis 50%